The Possible Role of Extravillous Trophoblast-Derived Exosomes on the Uterine Spiral Arterial Remodeling under Both Normal and Pathological Conditions

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Salomon, Carlos ^a   Yee, Sarah W ^a   Mitchell, Murray D ^a   Rice, Gregory E ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MESSENGER RNA; MICRORNA; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

AMNION FLUID; CELL COMMUNICATION; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; EXOSOME; EXTRAVILLOUS TROPHOBLAST; FETUS DEVELOPMENT; FIRST TRIMESTER PREGNANCY; HUMAN; INFLAMMATION; MICROENVIRONMENT; NIDATION; OXYGEN TENSION; PLACENTA; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; REPRODUCTION; REVIEW; TARGET CELL; TROPHOBLAST; UTERINE ARTERY; UTERINE SPIRAL ARTERY; BIOLOGICAL MODEL; CHORION VILLUS; FEMALE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

CHORIONIC VILLI; EXOSOMES; FEMALE; HUMANS; MODELS, CARDIOVASCULAR; PRE-ECLAMPSIA; PREGNANCY; TROPHOBLASTS; UTERINE ARTERY;

EID: 84930884029     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/693157     Document Type: Review

References (96)

1. M. Lappas and G. E. Rice, "Transcriptional regulation of the processes of human labour and delivery, " Placenta, vol. 30, pp. S90-S95, 2009.
2. N. M. Gude, C. T. Roberts, B. Kalionis, and R. G. King, "Growth and function of the normal human placenta, " Thrombosis Research, vol. 114, no. 5-6, pp. 397-407, 2004.
3. E. P. Y. Kam, L. Gardner, Y. W. Loke, and A. King, "The role of trophoblast in the physiological change in decidual spiral arteries, " Human Reproduction, vol. 14, no. 8, pp. 2131-2138, 1999.
4. R. Pijnenborg, E. Ball, J. N. Bulmer, M. Hanssens, S. C. Robson, and L. Vercruysse, "In vivo analysis of trophoblast cell invasion in the human, " Methods in molecular medicine., vol. 122, pp. 11-44, 2006.
5. R. Pijnenborg, J. M. Bland, W. B. Robertson, and I. Brosens, "Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy, " Placenta, vol. 4, no. 4, pp. 397-413, 1983.
6. C. A. Blackburn, J. A. Keelan, R. S. Taylor, and R. A. North, "Maternal serum activin A is not elevated before preeclampsia in women who are at high risk, " American Journal of Obstetrics and Gynecology, vol. 188, no. 3, pp. 807-811, 2003.
7. American Diabetes Association, "Diagnosis and classification of diabetes mellitus, " Diabetes Care, vol. 35, supplement 1, pp. S64-S71, 2012.
8. J. D. Boyd and W. J. Hamilton, The Human Placenta, W. Heffer & Sons, Cambridge, UK, 1970.
9. R. J. Simpson, S. S. Jensen, and J. W. E. Lim, "Proteomicprof iling of exosomes: current perspectives, " Proteomics, vol. 8, no. 19, pp. 4083-4099, 2008.
10. R. J. Simpson, J. W. E. Lim, R. L. Moritz, and S. Mathivanan, "Exosomes: proteomic insights and diagnostic potential, " Expert Review of Proteomics, vol. 6, no. 3, pp. 267-283, 2009.
11. H. Kalra, C. G. Adda, M. Liem, et al., "Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma, " Proteomics, vol. 13, no. 22, pp. 3354-3364, 2013.
12. C. V. Harding, J. E. Heuser, and P. D. Stahl, "Exosomes: looking back three decades and into the future, " Journal of Cell Biology, vol. 200, no. 4, pp. 367-371, 2013.
13. F. Lyall, "Priming and remodelling of human placental bed spiral arteries during pregnancy: a Review, " Placenta, vol. 26, pp. S31-S36, 2005.
14. G. J. Burton, A. W. Woods, E. Jauniaux, and J. C. P. Kingdom, "Rheological and physiological consequences of conversion of thematernal spiral arteries for uteroplacental blood flow during human pregnancy, " Placenta, vol. 30, no. 6, pp. 473-482, 2009.
15. K. Benirschke and P. Kaufmann, Pathology of the Human Placenta, 2000.
16. G. S. J. Whitley and J. E. Cartwright, "Cellular and molecular regulation of spiral artery remodelling: lessons fromthe cardiovascular field, " Placenta, vol. 31, no. 6, pp. 465-474, 2010.
17. R. Pijnenborg, L. Vercruysse, and M. Hanssens, "The uterine spiral arteries in human pregnancy: facts and controversies, " Placenta, vol. 27, no. 9-10, pp. 939-958, 2006.
18. R. Pijnenborg, J. M. Bland, W. B. Robertson, G. Dixon, and I. Brosens, "The pattern of interstitial trophoblastic invasion of the myometrium in early human pregnancy, " Placenta, vol. 2, no. 4, pp. 303-316, 1981.
19. R. Pijnenborg, G. Dixon, W. B. Robertson, and I. Brosens, "Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy, " Placenta, vol. 1, no. 1, pp. 3-19, 1980.
20. G. J. Burton, E. Jauniaux, and A. L. Watson, "Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited, " The American Journal of Obstetrics and Gynecology, vol. 181, no. 3, pp. 718-724, 1999.
21. J. N. Bulmer, B. A. Innes, J. Levey, S. C. Robson, and G. E. Lash, "The role of vascular smooth muscle cell apoptosis and migration during uterine spiral artery remodeling in normal human pregnancy, " The FASEB Journal, vol. 26, no. 7, pp. 2975-2985, 2012.
22. G. J. Burton, E. Jauniaux, and D. S. Charnock-Jones, "The influence of the intrauterine environment on human placental development, " International Journal of Developmental Biology, vol. 54, no. 2-3, pp. 303-311, 2010.
23. F. Rodesch, P. Simon, C. Donner, and E. Jauniaux, "Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy, " Obstetrics and Gynecology, vol. 80, no. 2, pp. 283-285, 1992.
24. E. Jauniaux, B. Gulbis, and G. J. Burton, "Physiological implications of the materno-fetal oxygen gradient in human early pregnancy, " Reproductive BioMedicine Online, vol. 7, no. 2, pp. 250-253, 2003.
25. F. Lyall, "Mechanisms regulating cytotrophoblast invasion in normal pregnancy and pre-eclampsia, " Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 46, no. 4, pp. 266-273, 2006.
26. Y. Wang and S. Zhao, Vascular Biology of the Placenta, Morgan & Claypool Life Sciences, San Rafael, Calif, USA, 2010.
27. A. M. Borzychowski, I. L. Sargent, and C. W. G. Redman, "Inflammation and pre-eclampsia, " Seminars in Fetal and Neonatal Medicine, vol. 11, no. 5, pp. 309-316, 2006.
28. C. W. G. Redman and I. L. Sargent, "Preeclampsia and the systemic inflammatory response, " Seminars in Nephrology, vol. 24, no. 6, pp. 565-570, 2004.
29. B. D. LaMarca, M. J. Ryan, J. S. Gilbert, S. R. Murphy, and J. P. Granger, "Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia, " Current Hypertension Reports, vol. 9, no. 6, pp. 480-485, 2007.
30. R. Raghupathy, "Cytokines as key players in the pathophysiology of preeclampsia, " Medical Principles and Practice, vol. 22, supplement 1, pp. 8-19, 2013.
31. H.-L. Chen, Y. Yang, X. L. Hu, K. K. Yelavarthi, J. L. Fishback, and J. S. Hunt, "Tumor necrosis factor alphamRNA and protein are present in human placental and uterine cells at early and late stages of gestation, " The American Journal of Pathology, vol. 139, no. 2, pp. 327-335, 1991.
32. G. Vince, S. Shorter, P. Starkey, et al., "Localization of tumour necrosis factor production in cells at the materno/fetal interface in human pregnancy, " Clinical and Experimental Immunology, vol. 88, no. 1, pp. 174-180, 1992.
33. M.-M. Philippeaux and P. F. Piguet, "Expression of tumor necrosis factor-κ and its mRNA in the endometrial mucosa during themenstrual cycle, " The American Journal of Pathology, vol. 143, no. 2, pp. 480-486, 1993.
34. P. P. Jokhi, A. King, A. M. Sharkey, S. K. Smith, and Y. W. Loke, "Screening for cytokine messenger ribonucleic acids in purified human decidual lymphocyte populations by the reverse-transcriptase polymerase chain reaction, " Journal of Immunology, vol. 153, no. 10, pp. 4427-4435, 1994.
35. S. Bauer, J. Pollheimer, J. Hartmann, P. Husslein, J. D. Aplin, and M. Knofler, "Tumor necrosis factor-κ inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures, " Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 2, pp. 812-822, 2004.
36. S. Goetze, X.-P. Xi, Y. Kawano, et al., "TNF-α-induced migration of vascular smooth muscle cells is MAPK dependent, " Hypertension, vol. 33, no. 1, part 2, pp. 183-189, 1999.
37. N. Laham, S. P. Brennecke, K. Bendtzen, and G. E. Rice, "Tumour necrosis factor β during human pregnancy and labour: maternal plasma and amniotic fluid concentrations and release from intrauterine tissues, " European Journal of Endocrinology, vol. 131, no. 6, pp. 607-614, 1994.
38. N. Laham, F. Van Dunne, L. J. Abraham, et al., "Tumor necrosis factor-κ in human pregnancy and labor, " Journal of Reproductive Immunology, vol. 33, no. 1, pp. 53-69, 1997.
39. M. T. Coughlan, K. Oliva, H. M. Georgiou, J. M. H. Permezel, and G. E. Rice, "Glucose-induced release of tumour necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus, " Diabetic Medicine, vol. 18, no. 11, pp. 921-927, 2001.
40. S. Haider and M. Knofler, "Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium, " Placenta, vol. 30, no. 2, pp. 111-123, 2009.
41. R. Pijnenborg, P. J. McLaughlin, L. Vercruysse, et al., "Immunolocalization of tumour necrosis factor-κ (TNF-α) in the placental bed of normotensive and hypertensive human pregnancies, " Placenta, vol. 19, no. 4, pp. 231-239, 1998.
42. M. Knofler, B. Mosl, S. Bauer, G. Griesinger, and P. Husslein, "TNF-β/TNFRI in primary and immortalized first trimester cytotrophoblasts, " Placenta, vol. 21, no. 5-6, pp. 525-535, 2000.
43. C. Rusterholz, S. Hahn, and W. Holzgreve, "Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia, " Seminars in Immunopathology, vol. 29, no. 2, pp. 151-162, 2007.
44. M. A. Williams, A. Farrand, R. Mittendorf, et al., "Maternal second trimester serum tumor necrosis factor-κ-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia, " American Journal of Epidemiology, vol. 149, no. 4, pp. 323-329, 1999.
45. F. Xie, Y. Hu, S. E. Turvey, et al., "Toll-like receptors 2 and 4 and the cryopyrin inflammasome in normal pregnancy and preeclampsia, " BJOG, vol. 117, no. 1, pp. 99-108, 2010.
46. F. Xie, S. E. Turvey, M. A. Williams, G. Mor, and P. von Dadelszen, "Toll-like receptor signaling and pre-eclampsia, "The American Journal of Reproductive Immunology, vol. 63, no. 1, pp. 7-16, 2010.
47. Y. Hamai, T. Fujii, T. Yamashita, et al., "Evidence for an elevation in seruminterleukin-2 and tumor necrosis factor-κ levels before the clinical manifestations of preeclampsia, " American Journal of Reproductive Immunology, vol. 38, no. 2, pp. 89-93, 1997.
48. F. Kalantar, S. Rajaei, A. B. Heidari, et al., "Serum levels of tumor necrosis factor-alpha, interleukin-15 and interleukin-10 in patients with pre-eclampsia in comparison with normotensive pregnantwomen, " Iranian Journal of Nursing and Midwifery Research, vol. 18, no. 6, pp. 463-466, 2013.
49. S. Y. Lau, S.-J. Guild, C. J. Barrett, et al., "Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis, " The American Journal of Reproductive Immunology, vol. 70, no. 5, pp. 412-427, 2013.
50. C. Xie, M. Z. Yao, J. B. Liu, and L. K. Xiong, "Ameta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia, " Cytokine, vol. 56, no. 3, pp. 550-559, 2011.
51. H. G. Zhang, C. Liu, K. Su, et al., "A membrane form of TNFalpha presented by exosomes delays T cell activation-induced cell death, " Journal of Immunology, vol. 176, no. 12, pp. 7385-7393, 2006.
52. Y. Chen, W. Ge, L. Xu, et al., "miR-200b is involved in intestinal fibrosis of Crohn's disease, " International Journal of Molecular Medicine, vol. 29, no. 4, pp. 601-606, 2012.
53. S. Atay, C. Gercel-Taylor, M. Kesimer, and D. D. Taylor, "Morphologic and proteomic characterization of exosomes released by cultured extravillous trophoblast cells, " Experimental Cell Research, vol. 317, no. 8, pp. 1192-1202, 2011.
54. S. Atay, C. Gercel-Taylor, J. Suttles, G. Mor, and D. D. Taylor, "Trophoblast-derived exosomes mediate monocyte recruitment and differentiation, " American Journal of Reproductive Immunology, vol. 65, no. 1, pp. 65-77, 2011.
55. J. Armitage, L. Poston, and P. Taylor, "Developmental origins of obesity and the metabolic syndrome: the role of maternal obesity, " Frontiers of Hormone Research, vol. 36, pp. 73-84, 2007.
56. D. D. Taylor and C. Gercel-Taylor, "Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects, " British Journal of Cancer, vol. 92, no. 2, pp. 305-311, 2005.
57. C. Thery, "Exosomes: secreted vesicles and intercellular communications, " F1000 Biology Reports, vol. 3, no. 1, article 15, 2011.
58. C. Salomon, J. Ryan, L. Sobrevia, et al., "Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis, " PLoS ONE, vol. 8, no. 7, Article ID e68451, 2013.
59. A. V. Vlassov, S. Magdaleno, R. Setterquist, and R. Conrad, "Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials, " Biochimicaet Biophysica Acta: General Subjects, vol. 1820, no. 7, pp. 940-948, 2012.
60. M. Simons and G. Raposo, "Exosomes-vesicular carriers for intercellular communication, " Current Opinion in Cell Biology, vol. 21, no. 4, pp. 575-581, 2009.
61. C. Lasser, V. S. Alikhani, K. Ekstrom, et al., "Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages, " Journal of Translational Medicine, vol. 9, article 9, 2011.
62. S. Keller, J. Ridinger, A.-K. Rupp, J. W. G. Janssen, and P. Altevogt, "Body fluid derived exosomes as a novel template for clinical diagnostics, " Journal of Translational Medicine, vol. 9, article 86, 2011.
63. M. Ostrowski, N. B. Carmo, S. Krumeich, et al., "Rab27a and Rab27b control different steps of the exosome secretion pathway, " Nature Cell Biology, vol. 12, no. 1, pp. 19-30, 2010.
64. C. Salomon, M. J. Torres, M. Kobayashi, et al., "A gestational profile of placental exosomes in maternal plasma and their effects on endothelial cell migration, " PLoS ONE, vol. 9, no. 6, Article ID e98667, 2014.
65. C. Salomon, M. Kobayashi, K. Ashman, L. Sobrevia, M. D. Mitchell, and G. E. Rice, "Hypoxia-induced changes in the bioactivity of cytotrophoblast-derived exosomes, " PLoS ONE, vol. 8, no. 11, Article ID e79636, 2013.
66. D. M. Pegtel, K. Cosmopoulos, D. A. Thorley-Lawson, et al., "Functional delivery of viral miRNAs via exosomes, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 14, pp. 6328-6333, 2010.
67. K. J. Svensson, H. C. Christianson, A. Wittrup, et al., "Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid raft-mediated endocytosis negatively regulated by caveolin-1, "The Journal of Biological Chemistry, vol. 288, no. 24, pp. 17713-17724, 2013.
68. M. Kobayashi, "Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200, " Journal of Translational Medicine, vol. 12, article 4, 2014.
69. H. Valadi, "Exosomes contain a selective number of mRNA and microRNA, " Allergy, vol. 62, p. 372, 2007.
70. M. Record, K. Carayon, M. Poirot, and S. Silvente-Poirot, "Exosomes as new vesicular lipid transporters involved in cellcell communication and various pathophysiologies, " Biochimicaet Biophysica Acta-Molecular and Cell Biology of Lipids, vol. 1841, no. 1, pp. 108-120, 2014.
71. A. Sabapatha, C. Gercel-taylor, and D. D. Taylor, "Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences, " American Journal of Reproductive Immunology, vol. 56, no. 5-6, pp. 345-355, 2006.
72. C. W. G. Redman and I. L. Sargent, "Circulating microparticles in normal pregnancy and pre-eclampsia, " Placenta, vol. 29, pp. S73-S77, 2008.
73. S.-S. Luo, O. Ishibashi, G. Ishikawa, et al., "Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes, " Biology of Reproduction, vol. 81, no. 4, pp. 717-729, 2009.
74. A. Inagaki, H. Nishizawa, S. Ota, et al., "Upregulation of HtrA4 in the placentas of patientswith severe pre-eclampsia, " Placenta, vol. 33, no. 11, pp. 919-926, 2012.
75. L. K. Harris, S. D. Smith, R. J. Keogh, et al., "Trophoblast-and vascular smooth muscle cell-derived MMP-12 mediates elastolysis during uterine spiral artery remodeling, " The American Journal of Pathology, vol. 177, no. 4, pp. 2103-2115, 2010.
76. L. K. Harris, "IFPA Gabor Than Award lecture: transformation of the spiral arteries in human pregnancy: key events in the remodelling timeline, " Placenta, vol. 32, no. 2, pp. S154-S158, 2011.
77. A. C. Stenqvist, O. Nagaeva, V. Baranov, and L. Mincheva-Nilsson, "Exosomes secreted by human placenta carry functional Fas ligand and TRAILmolecules and convey apoptosis in activated immune cells, suggesting exosome-mediated immune privilege of the fetus, " The Journal of Immunology, vol. 191, no. 11, pp. 5515-5523, 2013.
78. E. Delorme-Axford, R. B. Donker, J. F. Mouillet, et al., "Human placental trophoblasts confer viral resistance to recipient cells, " Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 29, pp. 12048-12053, 2013.
79. H. D. Lee, Y. H. Kim, and D. S. Kim, "Exosomes derived from human macrophages suppress endothelial cell migration by controlling integrin trafficking, " European Journal of Immunology, vol. 44, no. 4, pp. 1156-1169, 2014.
80. S. Taverna, A. Flugy, L. Saieva, et al., "Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis, " International Journal of Cancer, vol. 130, no. 9, pp. 2033-2043, 2012.
81. J. Esser, U. Gehrmann, F. L. DAlexand ri, et al., "Exosomes from human macrophages and dendritic cells contain enzymes for leukotriene biosynthesis and promote granulocyte migration, " Journal of Allergy and Clinical Immunology, vol. 126, no. 5, pp. 1032. e4-1040. e4, 2010.
82. I. Nazarenko, S. Rana, A. Baumann, et al., "Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation, " Cancer Research, vol. 70, no. 4, pp. 1668-1678, 2010.
83. E. Hergenreider, S. Heydt, K. Treguer, et al., "Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs, " Nature Cell Biology, vol. 14, no. 3, pp. 249-256, 2012.
84. P. Kucharzewska, H. C. Christianson, J. E. Welch, et al., "Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development, " Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 18, pp. 7312-7317, 2013.
85. R. B. Donker, J. F. Mouillet, T. Chu, et al., "The expression profile of C19MC microRNAs in primary human trophoblast cells and exosomes, "MolecularHuman Reproduction, vol. 18, no. 8, Article ID gas013, pp. 417-424, 2012.
86. S. Atay, C. Gercel-Taylor, and D. D. Taylor, "Human trophoblastderived exosomal fibronectin induces pro-inflammatory IL-1β production by macrophages, " American Journal of Reproductive Immunology, vol. 66, no. 4, pp. 259-269, 2011.
87. J. E. Cartwright, R. Fraser, K. Leslie, A. E. Wallace, and J. L. James, "Remodelling at the maternal-fetal interface: relevance to human pregnancy disorders, " Reproduction, vol. 140, no. 6, pp. 803-813, 2010.
88. E. A. Steegers, P. von Dadelszen, J. J. Duvekot, and R. Pijnenborg, "Pre-eclampsia, " The Lancet, vol. 376, no. 9741, pp. 631-644, 2010.
89. S. Lorquet, C. Pequeux, C. Munaut, and J.-M. Foidart, "Aetiology and physiopathology of preeclampsia and related forms, " Acta Clinica Belgica, vol. 65, no. 4, pp. 237-241, 2010.
90. C. W. G. Redman, D. S. Tannetta, R. A. Dragovic, et al., "Review: does size matter? Placental debris and the pathophysiology of pre-eclampsia, " Placenta, vol. 33, supplement, pp. S48-S54, 2012.
91. M. Knight, C. W. G. Redman, E. A. Linton, and I. L. Sargent, "Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies, " British Journal of Obstetrics and Gynaecology, vol. 105, no. 6, pp. 632-640, 1998.
92. D. S. Tannetta, R. A. Dragovic, C. Gardiner, C. W. Redman, and I. L. Sargent, "Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin, " PLoS ONE, vol. 8, no. 2, Article ID e56754, 2013.
93. R. A. Dragovic, J. H. Southcombe, D. S. Tannetta, C. W. Redman, and I. L. Sargent, "Multicolor flow cytometry and nanoparticle tracking analysis of extracellular vesicles in the plasma of normal pregnant and pre-eclamptic women, " Biology of Reproduction, vol. 89, no. 6, p. 151, 2013.
94. C. W. G. Redman, D. S. Tannetta, R. A. Dragovic, et al., "Review: does size matter? Placental debris and the pathophysiology of pre-eclampsia, " Placenta, vol. 33, pp. S48-S54, 2012.
95. A. Vargas, S. Zhou, M. Ethier-Chiasson, et al., "Syncytin proteins incorporated in placenta exosomes are important for cell uptake and show variation in abundance in serum exosomes from patients with preeclampsia, " FASEB Journal, vol. 28, no. 8, pp. 3703-3719, 2014.
96. D. Goswamia, D. S. Tannetta, L. A. Magee, et al., "Excess syncytiotrophoblast microparticle shedding is a feature of earlyonset pre-eclampsia, but not normotensive intrauterine growth restriction, " Placenta, vol. 27, no. 1, pp. 56-61, 2006.